GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (NAS:OGI) » Definitions » Cyclically Adjusted Revenue per Share

OrganiGram Holdings (OrganiGram Holdings) Cyclically Adjusted Revenue per Share : $0.96 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is OrganiGram Holdings Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

OrganiGram Holdings's adjusted revenue per share for the three months ended in Mar. 2024 was $0.305. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.96 for the trailing ten years ended in Mar. 2024.

During the past 12 months, OrganiGram Holdings's average Cyclically Adjusted Revenue Growth Rate was 8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-09), OrganiGram Holdings's current stock price is $1.58. OrganiGram Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.96. OrganiGram Holdings's Cyclically Adjusted PS Ratio of today is 1.65.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of OrganiGram Holdings was 23.70. The lowest was 1.09. And the median was 4.48.


OrganiGram Holdings Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for OrganiGram Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings Cyclically Adjusted Revenue per Share Chart

OrganiGram Holdings Annual Data
Trend Apr12 Apr13 Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.77

OrganiGram Holdings Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.88 0.91 0.97 0.96

Competitive Comparison of OrganiGram Holdings's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganiGram Holdings's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's Cyclically Adjusted PS Ratio falls into.



OrganiGram Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OrganiGram Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.305/126.2576*126.2576
=0.305

Current CPI (Mar. 2024) = 126.2576.

OrganiGram Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201401 0.000 97.261 0.000
201404 0.000 98.920 0.000
201407 0.000 99.315 0.000
201411 0.001 99.078 0.001
201502 0.004 99.078 0.005
201505 0.014 100.263 0.018
201508 0.039 100.579 0.049
201511 0.058 100.421 0.073
201602 0.073 100.421 0.092
201605 0.099 101.765 0.123
201608 0.083 101.686 0.103
201611 0.076 101.607 0.094
201702 -0.018 102.476 -0.022
201705 0.056 103.108 0.069
201708 0.056 103.108 0.069
201711 0.072 103.740 0.088
201802 0.082 104.688 0.099
201805 0.078 105.399 0.093
201808 0.075 106.031 0.089
201811 0.249 105.478 0.298
201902 0.589 106.268 0.700
201905 0.464 107.927 0.543
201908 0.291 108.085 0.340
201911 0.472 107.769 0.553
202002 0.424 108.559 0.493
202005 0.293 107.532 0.344
202008 0.300 108.243 0.350
202011 0.291 108.796 0.338
202102 0.198 109.745 0.228
202105 0.233 111.404 0.264
202108 0.264 112.668 0.296
202111 0.296 113.932 0.328
202202 0.322 115.986 0.351
202205 0.378 120.016 0.398
202208 0.449 120.569 0.470
202211 0.411 121.675 0.426
202302 0.376 122.070 0.389
202305 0.308 124.045 0.313
202312 0.335 125.072 0.338
202403 0.305 126.258 0.305

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


OrganiGram Holdings  (NAS:OGI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OrganiGram Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.58/0.96
=1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of OrganiGram Holdings was 23.70. The lowest was 1.09. And the median was 4.48.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


OrganiGram Holdings Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


OrganiGram Holdings (OrganiGram Holdings) Business Description

Industry
Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.